• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Sorafenib with or without transarterial chemoembolization for advanced hepatocellular carcinoma with

Sorafenib with or without transarterial chemoembolization for advanced hepatocellular carcinoma with

来源 :2016第十二届亚太介入放射学大会 | 被引量 : 0次 | 上传用户：enjoy12_east
【摘 要】
：
Background:The survival benefit of combining sorafenib and transarterial chemoembolization(TACE)therapy compared with sorafenib monotherapy for patients with advanced hepatocellular carcinoma(HCC)and
【作 者】
：
Ying-Qiang Zhang 
【机 构】
：
The First Affiliated Hospital,Sun Yat-sen University
【出 处】
：
2016第十二届亚太介入放射学大会
【发表日期】
：
2016年11期
【关键词】
：
Hepatocellular Carcinoma Main Portal Vein Tumor Thrombosis Transarterial Chemoem 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Background:The survival benefit of combining sorafenib and transarterial chemoembolization(TACE)therapy compared with sorafenib monotherapy for patients with advanced hepatocellular carcinoma(HCC)and main portal vein tumor thrombosis(MPVTT)is unclear.
其他文献
TACE and arterial infusion chemotherapy with FOLFOX regimen through indwelling catheter for BCLC Sta
Objective:To assess the therapeutic effect of TACE and arterial infusion chemotherapy with FOLFOX regimen(oxaliplatin,Calcium folinate,and floxuridine)through indwelling catheter in the Treatment for
会议
Primary Hepatocellular CarcinomaBCLCFOLFOX RegimenTACEIndwelling Catheter
Transarterial chemoembolization combined with cryoablation for unresectable large hepatocellular car
Aim:To evaluate the safety and efficacy of transarterial chemoembolization(TACE)combined with cryoablation in patients with large hepatocellular carcinoma(HCC).
会议
CarcinomaLarge HCCTACECryoablationCombined Treatment
Transarterial chemoembolization with gelatin sponge microparticles for large hepatocellular carcinom
Objective:The purpose of this investigation is to assess the safety and efficacy of transarterial chemoembolization(TACE)with gelatin sponge microparticles(GSMs)in the treatment of hepatocellular carc
会议
Hepatocellular CarcinomaGelatin Sponge MicroparticlesTransarterial Chemoemboli
Study of the Th1,Th2 type cytokines in the patients with HCC after GSMs-TACE
We found that the tumor necrosis and shrinkage were obvious after GSMs-TACE treatment for HCC.Moreover,it is uncommon for lymph node metastasis from HCC after GSMs-TACE.
会议
Gelatin Sponge MicroparticlesHepatocellular CarcinomaTh1/Th2 type CytokinesIm
Reconsidering sorafenib-related trial design:amulticenter cohort study on transarterial chemoemboliz
Background & Aims:We conducted this multicenter retrospective study to evaluate the efficacy of sorafenib combined with transarterial chemoembolization(TACE)compared to TACE monotherapy in intermediat
会议
Hepatocellular CarcinomaTransarterial ChemeombolizationSorafenib
Pre-Surgical embolization of nasopharyngeal angiofibroma,Pakistani experience
会议
NAF
Cavernous aneurysms-how we treat-70 cases
Objectives: To highlight the variable techniques for treating cavernous aneurysm depending upon its size/shape and clinical presentations.
会议
Cavernous
Experimental research on ozonated saline for treatment of VX-2 tumor
Objective:To investigate the effectiveness and safety of ozonated saline injected directly into tumor for treatment of VX-2 tumor and to explore the mechanism.
会议
Ozonated SalineCarcinomaVX-2 TumorTherapyEffectiveness
Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma aft
Aims:To assess the efficacy of continued administration of sorafenib for patients with unresectable hepatocellular carcinoma(HCC)treated with local regional therapy(LRT)after a complete response(CR),a
会议
Hepatocellular CarcinomaTransarterial ChemoembolizationRadiofrequency Ablation
Which criteria Aapplied in multi-phasic CT can predict early tumor response in patients with hepatoc
Purpose:To evaluate the performance of quantitative EASL(qEASL),a volumetric enhancement criterion,to assess tumor response and predict overall survival(OS)in patients with hepatocellular carcinoma(HC
会议
Hepatocellular CarcinomaTransarterial ChemeombolizationCTTumor Response